Cargando…

Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations

SARS-CoV-2 is the virus responsible for COVID-19, whose clinical spectrum ranges widely, both in terms of severity and multi-organicity. SARS-CoV-2 mainly involves the respiratory tract, causing from a flu-like syndrome to interstitial pneumonia and acute respiratory distress syndrome. Although its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vespa, Edoardo, Pugliese, Nicola, Colapietro, Francesca, Aghemo, Alessio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825983/ https://www.ncbi.nlm.nih.gov/pubmed/33521703 http://dx.doi.org/10.1016/j.tige.2021.01.006

Ejemplares similares

Liver tests abnormalities in COVID-19: trick or treat?
por: Vespa, Edoardo, et al.
Publicado: (2020)

COVID-19, ACEI/ARBs, and Gastrointestinal Symptoms: The Jury Is Still Out on the Association
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2021)

Fr492 SIGNIFICANTLY REDUCED MORTALITY IN COVID-19 PATIENTS WITH GASTROINTESTINAL MANIFESTATIONS
por: Livanos, Alexandra E., et al.
Publicado: (2021)

Effects of Dietary Yogurt on the Healthy Human Gastrointestinal (GI) Microbiome
por: Lisko, Daniel J., et al.
Publicado: (2017)

Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life
por: Pugliese, Nicola, et al.
Publicado: (2023)

Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy
por: Cecconi, Maurizio, et al.
Publicado: (2020)

COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy
por: Aghemo, Alessio, et al.
Publicado: (2020)

Stay on Top: COVID-19 As an Opportunity to Improve the GI Scientific Career – The Impact on Papers and Literature
por: Hassan, Cesare, et al.
Publicado: (2021)

COVID-19 and Its Impact on Upper Gastrointestinal (GI) Cancer Management
por: Fernando, Shalini, et al.
Publicado: (2021)

Fr095 AN ANALYSIS OF GI AND NON-GI MANIFESTATIONS OF COVID-19 DURING THE FIRST WAVE OF THE PANDEMIC IN DARLINGTON, UNITED KINGDOM
por: Dhar, Anjan, et al.
Publicado: (2021)

724. Gastrointestinal (GI) PCR vs Stool Cultures: Impact on Length of Hospital Stay (LOS) and Antibiotic Use
por: Singh, Vansha, et al.
Publicado: (2020)

Novel coronavirus (COVID-19) and its potential G.I. manifestation: A review
por: Deep, Amar, et al.
Publicado: (2020)

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization
por: Masetti, Chiara, et al.
Publicado: (2022)

Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients
por: Colapietro, Francesca, et al.
Publicado: (2023)

Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies
por: Dillon, Alexander B., et al.
Publicado: (2015)

The Role of Selected Serpins in Gastrointestinal (GI) Malignancies
por: Pączek, Sara, et al.
Publicado: (2022)

Implications of gastrointestinal manifestations of COVID-19
por: Yang, Lijing, et al.
Publicado: (2020)

Gastrointestinal and Liver Manifestations of COVID-19
por: Agarwal, Amol, et al.
Publicado: (2020)

Gastrointestinal and liver manifestations of COVID-19
por: Cheong, Janice, et al.
Publicado: (2020)

A “double-hit” damage mechanism can explain self-limited GI bleeding in COVID-19 pneumonia
por: Dioscoridi, Lorenzo, et al.
Publicado: (2021)

GI-COVID: Are There COVID-19 Patients with Primary Gastrointestinal SARS-CoV-2 Infection and Symptoms?
por: Ong, John, et al.
Publicado: (2021)

COVID-19: gastrointestinal and hepatobiliary manifestations()()
por: Shih, Angela R., et al.
Publicado: (2023)

Stay Connected and Up To Date: GI Meetings and Seminars and the Coronavirus Disease 2019 Pandemic
por: Albéniz, Eduardo, et al.
Publicado: (2021)

Radiation-induced gastrointestinal (GI) syndrome as a function of age
por: Li, Hongyan, et al.
Publicado: (2023)

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19
por: Patel, Kishan P., et al.
Publicado: (2020)

COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations
por: Vernia, Filippo, et al.
Publicado: (2023)

Gastrointestinal and Liver Manifestations in COVID-19 Population
por: Saleem, Saad, et al.
Publicado: (2021)

COVID-19: Impact on Endoscopy and GI Community
por: Maselli, Roberta
Publicado: (2021)

Anesthesia for GI endoscopy in the era of COVID-19
por: Goudra, Basavana, et al.
Publicado: (2021)

Sa1063: COVID AND COVID VACCINATION AMONG OUTPATIENTS WITH FUNCTIONAL GI AND GI MOTILITY DISORDERS; EFFECTS ON GI SYMPTOMS.
por: Silver, Paul, et al.
Publicado: (2022)

Focused update on Gastrointestinal (GI) Oncology from ASCO 2016
por: Paluri, Ravi Kumar
Publicado: (2016)

Vibrio cholerae Detection by the FilmArray® Gastrointestinal (GI) Panel
por: Clarke, Kimon, et al.
Publicado: (2017)

Gastrointestinal Manifestation of COVID-19 in Hospitalized Patients
por: Sukharani, Naintara, et al.
Publicado: (2021)

Gastrointestinal and liver manifestations in patients with COVID-19
por: Lee, I-Cheng, et al.
Publicado: (2020)

Clinical Insights into the Gastrointestinal Manifestations of COVID-19
por: Kopel, Jonathan, et al.
Publicado: (2020)

The Pathophysiology of Gastrointestinal and Hepatic Manifestations of COVID-19
por: Yousaf, Muhammad N, et al.
Publicado: (2020)

Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?
por: Solitano, Virginia, et al.
Publicado: (2021)

Microthrombosis associated with GI bleeding in COVID-19
por: Buckholz, Adam, et al.
Publicado: (2021)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Indolent T-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract (iTLPD-GI): A Review
por: Sanguedolce, Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dh82kep1o3kt63cu8mmp7m52jt